| Share-based compensation |
Note 11 — Share-based compensation The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands): | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | | June 30, | | June 30, | | | | 2025 | | 2024 | | 2025 | | 2024 | | Research and development | | $ | 305 | | $ | 994 | | $ | 173 | | $ | 1,808 | | Selling, general and administrative | | | 1,016 | | | 2,063 | | | 1,817 | | | 4,352 | | | | $ | 1,321 | | $ | 3,057 | | $ | 1,990 | | $ | 6,160 | |
The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted: | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | | June 30, | | June 30, | | | | 2025 | | 2024 | | 2025 | | 2024 | | Number of options over ordinary shares granted | | | 24,711,600 | | | 1,795,872 | | | 24,711,600 | | | 43,982,424 | | Weighted average fair value of ordinary shares options | | $ | 0.07 | | $ | 0.19 | | $ | 0.07 | | $ | 0.12 | | Number of additional options with a nominal exercise price granted | | | 24,944,376 | | | 2,540,640 | | | 24,944,376 | | | 30,655,824 | | Weighted average fair value of options with a nominal exercise price | | $ | 0.10 | | $ | 0.24 | | $ | 0.10 | | $ | 0.15 | |
|